Form 4 for IDXX Idexx Laboratories
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001567619-23-003224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-16 | 2023-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,010 | 3,879 | +35% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $503.65 | -305 | 3,747 | -8% | -$153.6K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | — | -1,010 | 2,197 | -31% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 483 | $0.00 | 3,524.99 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | M | A | 216 | $0.00 | 3,740.99 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-14 | F | D | 305 | $503.65 | 3,746.99 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | M | A | 173 | $0.00 | 4,051.99 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-14 | M | A | 138 | $0.00 | 3,878.99 | D | — | — | |
| 6 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 216 | — | 2,508 | D | — · — to — | 216 Common Stock | (F5) Not applicable. (F2) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 7 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 138 | — | 2,370 | D | — · — to — | 138 Common Stock | (F5) Not applicable. (F3) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 8 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 483 | — | 2,724 | D | — · — to — | 483 Common Stock | (F5) Not applicable. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 9 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 173 | — | 2,197 | D | — · — to — | 173 Common Stock | (F5) Not applicable. (F4) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |